Overview

Bioequivalence Study Between Capoten Versus Captopril Reference Product in Healthy Adult Participants Under Fasting Conditions

Status:
Not yet recruiting

Trial end date:
2022-01-14

Target enrollment:

Participant gender:

Summary

This is a bioequivalence study to compare Capoten (test product [T]) versus captopril (reference product [R]) produced by Mylan Pharmaceuticals Spain, in healthy adult participants under fasting condition. Capoten is the registered trademark of SmithKline Beecham Egypt.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Captopril